DSS, Inc. Continues Insider Sell‑Off of Impact Biomed Shares Amid Rising Investor Concerns
Impact Biomed insider sales signal a possible shift—DSS, INC. offloads 890k+ shares, raising doubts about near‑term prospects and hinting at strategic rebalancing.
3 minutes to read